Elif Karakoç Aydıner

Dr. Elif Karakoç Aydıner graduated from Cerrahapasa University, Faculty of Medicine in 2001. She has completed her residency of Pediatrics in 2006 and fellowship at Pediatric Immunology and Allergy in 2011 at Marmara University. She has been working at Marmara Medical Faculty, Department of Pediatrics since 2012 as a lecturer. She is experienced in diagnosis and treatment of primary immune deficiency disorders and allergic diseases of childhood. She has more than 100 publications and received more than 2000 citations with 20 h index value. Recently, Dr. Karakoç Aydıner is working on projects focused on personalised immunoglobulin replacement and targeted therapies in immune deficiencies in addition to natural history and immunotherapy of food allergies.

Relevant Literature:
1. Catak MC, Akcam B, Bilgic Eltan S, Babayeva R, Karakus IS, Akgun G, Baser D, Bulutoglu A, Bayram F, Kasap N, Kiykim A, Hancioglu G, Kokcu Karadag SI, Kendir Demirkol Y, Ozen S, Cekic S, Ozcan D, Edeer Karaca N, Sasihuseyinoglu AS, Cansever M, Ozek Yucel E, Tamay Z, Altintas DU, Aydogmus C, Celmeli F, Cokugras H, Gulez N, Genel F, Metin A, Guner SN, Kutukculer N, Keles S, Reisli I, Kilic SS, Yildiran A, Karakoc-Aydiner E, Lo B, Ozen A, Baris S. Comparing the levels of CTLA-4-dependent biological defects in patients with LRBA deficiency and CTLA-4 insufficiency. Allergy. 2022 May 1. doi: 10.1111/all.15331.

2. Cekic S, Huriyet H, Hortoglu M, Kasap N, Ozen A, Karakoc-Aydiner E, Metin A, Ocakoglu G, Demiroz Abakay C, Temel SG, Ozemri Sag S, Baris S, Cavas T, Sebnem Kilic S. Increased radiosensitivity and impaired DNA repair in patients with STAT3-LOF and ZNF341 deficiency, potentially contributing to malignant transformations. Clin Exp Immunol. 2022 Jul 22;209(1):83-89. doi: 10.1093/cei/uxac041.

3. Ozturk E, Catak MC, Kiykim A, Baser D, Bilgic Eltan S, Yalcin K, Kasap N, Nain E, Bulutoglu A, Akgun G, Can Y, Sefer AP, Babayeva R, Caki-Kilic S, Tezcan Karasu G, Yesilipek A, Ozen A, Karakoc-Aydiner E, Baris S. Clinical and Laboratory Factors Affecting the Prognosis of Severe Combined Immunodeficiency. J Clin Immunol. 2022 Apr 22. doi: 10.1007/s10875-022-01262-0.

4. Chatila TA, Benamar M, Chen Q, Chou J, Julé A, Boudra R, Contini P, Crestani E, Wang M, Fong J, Lai P, Rockwitz S, Lee P, Chan TMF, Altun EZ, Kepenekli E, Karakoc-Aydiner E, Ozen A, Boran P, Aygun F, Onal P, Sakalli AAK, Cokugras H, Gelmez M, Öktelik F, Cetin EA, Zhong Y, Taylor M, Irby K, Halasa N, Signa S, Prigione I, Gattorno M, Cotugno N, Amodio D, Geha R, Son MB, Newburger J, Agrawal P, Volpi S, Palma P, Kiykim A, Randolph A, Deniz G, Baris S, De Palma R, Schmitz-Abe K, Charbonnier LM, Henderson L. Notch1-CD22-Dependent Immune Dysregulation in the SARS-CoV2-Associated Multisystem Inflammatory Syndrome in Children. Res Sq [Preprint]. 2022 Apr 11:rs.3.rs-1054453. doi: 10.21203/rs.3.rs1054453/v1.

5. Kepenekli E, Yakut N, Ergenc Z, Aydıner Ö, Sarınoğlu RC, Karahasan A, KarakocAydıner E, Memişoğlu A, Gökdemir Y, Eralp EE, Ergenekon P, Karadağ B, Tezel KG, Aydın M, Şenyürek B, Boran P. COVID-19 disease characteristics in different pediatric age groups. J Infect Dev Ctries. 2022 Jan 31;16(1):16-24. doi: 10.3855/jidc.15353.

6. Karakoc Aydiner E, Bilgic Eltan S, Babayeva R, Aydiner O, Kepenekli E, Kolukisa B, Sefer AP, Yalcin Gungoren E, Karabiber E, Yucel EO, Ozdemir O, Kiykim A, Artac H, Yakici N, Yalcin K, Cokugras H, Celkan TT, Orhan F, Yesilipek MA, Baris S, Ozen A. Adverse COVID-19 outcomes in immune deficiencies: Inequality exists between subclasses. Allergy. 2022 Jan;77(1):282-295. doi: 10.1111/all.15025

7. Rodríguez Del Río P, Alvarez-Perea A, Blumchen K, Caimmi D, Caubet JC, Konstantinopoulos AP, Riggioni C, Fassio F, Karakoc-Aydiner E, Le TM, Patel N, Savolainen J, Vazquez-Ortiz M, Alvaro Lozano M. Food immunotherapy practice: Nation differences across Europe, the FIND project. Allergy. 2022 Mar;77(3):920-932. doi: 10.1111/all.15016.

CV PDF